Table 1 Baseline characteristics of all enrolled patients with cardiovascular diseases.
From: Sleep-disordered breathing profiles in patients with cardiovascular diseases: Kurume SDB-CVD study
Total | Male | Female | P value (Male vs. Female) | |
---|---|---|---|---|
n (%) | 5765 | 3523 (61.1) | 2242 (38.9) | |
Age, years old | 66.5 ± 14.4 | 65.7 ± 13.8 | 67.7 ± 15.1 | < 0.001 |
SpO2 at awakening, % | 94.2 ± 2.2 | 94.3 ± 2.0 | 94.0 ± 2.6 | < 0.001 |
Systolic blood pressure, mmHg | 122.0 ± 18.6 | 122.9 ± 18.2 | 120.6 ± 19.2 | < 0.001 |
Diastolic blood pressure, mmHg | 70.7 ± 12.8 | 71.6 ± 12.9 | 69.2 ± 12.5 | < 0.001 |
Pulse pressure, mmHg | 51.3 ± 15.6 | 51.2 ± 15.3 | 51.4 ± 16.1 | 0.692 |
Pulse rate, bpm | 72.7 ± 14.6 | 71.7 ± 14.4 | 74.3 ± 14.8 | < 0.001 |
BMI, kg/m2 | 23.4 ± 3.9 | 23.8 ± 3.6 | 22.9 ± 4.1 | < 0.001 |
WBC, /μL | 5964 ± 2031 | 6104 ± 1970 | 5745 ± 2105 | < 0.001 |
Hb, g/dL | 13.2 ± 2.0 | 13.7 ± 2.0 | 12.5 ± 3.7 | < 0.001 |
HbA1c, % | 6.1 ± 0.8 | 6.2 ± 0.9 | 6.0 ± 0.8 | < 0.001 |
Serum creatinin, mg/dL | 1.25 ± 1.66 | 1.42 ± 1.84 | 0.97 ± 1.31 | < 0.001 |
Serum sodium, mEq/L | 140.7 ± 2.8 | 140.5 ± 2.8 | 141.0 ± 2.8 | < 0.001 |
NT-proBNP, pg/mL | 2855 ± 13,014 | 2899 ± 13,377 | 2787 ± 12,427 | 0.759 |
CTR (chest X-ray), % | 51.1 ± 7.1 | 49.7 ± 6.6 | 53.4 ± 7.5 | < 0.001 |
LVEF, % | 60.7 ± 14.7 | 58.9 ± 14.9 | 63.5 ± 13.9 | < 0.001 |
3%ODI < 5, (%) | 2067 (35.9) | 1092 (31.0) | 975 (43.5) | < 0.001 (Mantel–Haenszel test) |
5 ≤ 3%ODI < 15, (%) | 2426 (42.1) | 1495 (42.4) | 931 (41.5) | |
15 ≤ 3%ODI < 30, (%) | 975 (16.9) | 704 (20.0) | 271 (12.1) | |
30 ≤ 3%ODI, (%) | 297 (5.2) | 232 (6.6) | 65 (2.9) |